Quality Study and Validation Platform 

Led and supported by Guangdong Provincial Science & Technology Department and Guangdong FDA, SCCIP and Guangdong Institute for Drug Quality have jointly set up “Drug Quality Study and Validation Platform of SCCIP” and “Experimental Base of Guangdong Institute for Drug Quality”. A series of modern advanced instruments and devices are available such as NMR, MS, preparative LC, LC/MS, LC, GC, separation and purification systems in the platform which provides the good hardware foundation for the study, validation and inspection on new drugs. 

At present, Guangdong Institute for Drug Quality has renovated the third floor of Building F in SCCIP to be as their externally-extended experimental base, where 20 scientific and technical personnel (including two PhD degree graduates and 4 Master degree graduates) have entered into the experimental base of SCCIP to participate in the study, validation and analysis in the light of the platform thereby providing the specialized services for quality study and validation of new drug at a high level.